--- title: "DINGDANG HEALTH practices policy orientation through technology, with AI as the core engine of inclusive health services" type: "News" locale: "en" url: "https://longbridge.com/en/news/287150828.md" description: "DINGDANG HEALTH, supported by national policies, has deeply integrated AI technology into the health service system and launched the AI health assistant \"Smart DINGDANG,\" achieving intelligent analysis and medication guidance for common ailments. By integrating online and offline services, it has built a service closed loop of \"intelligent consultation - scientific medication recommendation - instant home delivery,\" enhancing operational efficiency and user experience, and promoting the company's transformation from a drug delivery platform to a one-stop health service platform" datetime: "2026-05-21T03:16:33.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/287150828.md) - [en](https://longbridge.com/en/news/287150828.md) - [zh-HK](https://longbridge.com/zh-HK/news/287150828.md) --- # DINGDANG HEALTH practices policy orientation through technology, with AI as the core engine of inclusive health services Under the strong promotion of the "Artificial Intelligence +" initiative by the state and the clear encouragement of AI applications in health management and assisted diagnosis, artificial intelligence is becoming a key driving force for the upgrade of the healthcare industry. DINGDANG HEALTH Group actively responds to the policy call of "Artificial Intelligence + Healthcare," deeply integrating AI technology into its comprehensive service system of "pharmaceutical inspection and insurance," reshaping the health service paradigm through technological innovation, and promoting services to evolve towards more inclusive, efficient, and personalized directions. The core of DINGDANG HEALTH's practice lies in transforming AI into actionable and scalable service capabilities. Its self-developed AI health assistant "Smart DINGDANG" has been selected as one of the 2026 China Innovative AI Products, with vertical scene AI applications gaining attention. Other products selected at the same time include Alibaba's Qwen and ByteDance's Seedance 2.0. It is understood that Smart DINGDANG fully accesses industry-leading large models, capable of handling over 80% of common disease consultations, achieving intelligent analysis of hundreds of disease symptoms and safe medication guidance. This not only reflects technological strength but also vividly practices the transformation of national policies on "optimizing intelligent service processes" and "strengthening health management" into concrete user value. In the context of instant retail moving towards a trillion-scale industry, AI has become a key infrastructure for DINGDANG Kuaibao to enhance core operational efficiency and user experience. Through the collaboration of "Smart DINGDANG" with offline smart pharmacies and instant delivery networks, the company has built a complete service closed loop of "intelligent consultation - scientific medication recommendation - instant home delivery." At the same time, its underlying intelligent system "Xingyuan" and its intelligent warehousing network have significantly improved picking efficiency and optimized operational costs, solidifying the fulfillment capability of "delivery in 28 minutes" and even "urgent delivery in 15 minutes" from the bottom of the supply chain. This model of "empowering intelligent systems and integrating online and offline" precisely aligns with the current trend of instant and scenario-based health consumption. Industry insiders believe that DINGDANG HEALTH's systematic layout of AI goes beyond mere technical application and is essentially a strategic choice aimed at cultivating new productive forces in health services for the future. Driven by both policy support and market demand, the technological capabilities represented by AI are assisting it in evolving from a "pharmaceutical delivery platform" to a "one-stop health service platform," not only building differentiated competitive barriers but also providing a valuable reference path for the transformation and upgrading of the entire pharmaceutical retail industry in the "Artificial Intelligence +" era ### Related Stocks - [09886.HK](https://longbridge.com/en/quote/09886.HK.md) - [09988.HK](https://longbridge.com/en/quote/09988.HK.md) - [BABA.US](https://longbridge.com/en/quote/BABA.US.md) - [89988.HK](https://longbridge.com/en/quote/89988.HK.md) - [HBBD.SG](https://longbridge.com/en/quote/HBBD.SG.md) ## Related News & Research - [Trillion-dollar Samsung faces a battle over who gets the AI profits](https://longbridge.com/en/news/287013238.md) - [eClerx Unifies AI Leadership to Deliver Outcome-Driven Results at Enterprise Scale](https://longbridge.com/en/news/287096511.md) - [How AI is changing your investing game](https://longbridge.com/en/news/287144820.md) - [AI investment 'advice' is 50% more likely to pump you up - and trip you into costly blunders](https://longbridge.com/en/news/286651216.md) - [08:10 ETPublic Opinion Emerges as an Early Warning System for the Hidden Risks of AI Dependency](https://longbridge.com/en/news/287062274.md)